Abstract
The invention relates to the use of a compound selected from an aminopeptidase-inhibiting compound and an azaindole compound for producing a drug for preventing or treating cancerous metastases in humans or animals.
Claims
- 1-10. (canceled)
- A method for the prevention or treatment of cancerous metastases in humans or animals consisting in administering a compound selected from an aminopeptidase inhibitor compound and an azaindole compound.
- The method of claim 11, wherein the aminopeptidase inhibitor compound is the compound of formula (I) below:
-
The method of claim 11, wherein the azaindole compound is the compound of formula (II) below:
in which the group R1 is a linear or branched alkyl having from 1 to 6 carbon atoms.
-
The method of claim 11, wherein the azaindole compound is the compound of formula (III) below:
in which the groups R1, R2, R3, and R4 each represent, independently of one another, an alkyl of 1 to 6 carbon atoms.
- The method of claim 11, wherein the azaindole compound is the compound of formula (IV) below: in which the groups R1, R2, and R3 each represent, independently of one another, a halogen selected from F, Cl, I, and Br.
-
The method of claim 11, wherein the azaindole compound is the compound of formula (V) below:
in which:
the group R1 is a halogen selected from F, Cl, I, and Br, and
the group R2 is a linear or branched alkyl having from 1 to 6 carbon atoms.
-
The method of claim 11, wherein the azaindole compound is the compound of formula (VI) below:
in which the group R1 is a halogen selected from F, Cl, I, and Br.
-
The method of claim 11, wherein the azaindole compound is selected from the following compounds:
methyl 4-[([3-(4-fluorophenyl)-4-oxo-2-thioxo-1,3-thiazolidin-5-ylidene)methyl)benzoate;
3,4,5-triethoxy-N-(2-methyl-4-nitrophenyl)benzamide;
5-(5-bromo-3-chloro-2-hydroxybenzylidene)-1-(4-chlorophenyl)-2,4,6-(1H,3H,5H)pyrimidinetrione;
5-bromo-N-(4-butoxyphenyl)nicotinamide; and
3-chloro-1-phenyl-4-[(2-phenylethyl)amino]-1H-pyrrole-2,5-dione.
- The method of claim 11, wherein said medicament is intended for the prevention or treatment of epithelial cancers.
- The method of claim 19, wherein the epithelial cancer is selected from a colorectal cancer and a breast cancer.
Owners (US)
-
Centre National De La Recherche Scientifique
(Aug 30 2010)
Explore more patents:
Applicants
-
Centre Nat Rech Scient
Explore more patents:
Inventors
-
Roux Pierre
Explore more patents:
-
De Toledo Marion
Explore more patents:
-
Leonetti Jean-paul
Explore more patents:
-
Anguille Christelle
Explore more patents:
CPC Classifications
-
A61K31/167
Explore more patents:
-
A61K31/402
Explore more patents:
-
A61K31/4174
Explore more patents:
-
A61K31/437
Explore more patents:
-
A61K31/455
Explore more patents:
-
A61K31/513
Explore more patents:
-
A61K31/517
Explore more patents:
IPC Classifications
-
A61K31/497
Explore more patents:
-
A61K31/136
Explore more patents:
-
A61K31/4164
Explore more patents:
-
A61K31/426
Explore more patents:
-
A61K31/44
Explore more patents:
-
A61K31/505
Explore more patents:
-
A61K31/517
Explore more patents:
-
A61P35/00
Explore more patents:
US Classifications
-
514/254.03
Explore more patents:
-
514/266.31
Explore more patents:
-
514/646
Explore more patents:
-
514/274
Explore more patents:
-
514/355
Explore more patents:
-
514/391
Explore more patents:
-
514/365
Explore more patents:
Document Preview
- Publication: Feb 24, 2011
-
Application:
Jan 21, 2009
US 81250109 A
-
Priority:
Jan 21, 2009
FR 2009050081 W
-
Priority:
Jan 22, 2008
FR 0850389 A